1 – 10 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program
- 2015
- Immunohistochemical analysis of CD70 expression in 95 cases of squamous cell carcinoma of the head and neck: correlation with clinicopathological variables and identification of a novel therapeutic target
- Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2
- Evaluation of abiraterone acetate post-docetaxel in the Belgian compassionate use program
- Battling resistance mechanisms in antihormonal prostate cancer treatment: novel agents and combinations
- Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis
- G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
- Congress highlights: ECCO-ESMO 2015 special edition: highlights in genitourinary cancers from the 18th ECCO – 40th ESMO European cancer congress
- Congress highlights: ASCO 2015 special edition: highlights in genitourinary cancers from the 2015 ASCO annual meeting
- A phase I study of volasertib combined with afatinib, in advanced solid tumors